Bone loss – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 10:59:55 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Bone loss – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of Phenoxymethylpenicillin Potassium and Amoxicillin for Patients Needing Oral Bone Augmentation https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-phenoxymethylpenicillin-potassium-and-amoxicillin-for-patients-needing-oral-bone-augmentation/ Wed, 29 Apr 2026 14:58:14 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-phenoxymethylpenicillin-potassium-and-amoxicillin-for-patients-needing-oral-bone-augmentation/ This clinical trial is focused on the use of antibiotics during dental procedures that involve building up bone in the mouth, known as oral bone augmentation. The study is examining two antibiotics: phenoxymethylpenicillin potassium, marketed as Kåvepenin, and amoxicillin, marketed as Amimox. These medications are being tested to see how effective they are in preventing infections after dental implant surgeries that require bone augmentation.

The purpose of the study is to evaluate whether a short course or a longer course of antibiotics is more effective in preventing infections after these dental procedures. Participants in the study will receive either one of the antibiotics or a placebo. The study will monitor for signs of infection, such as swelling, pain, or pus in the surgical area, and will also look at how well the bone material and dental implants survive over time.

Throughout the study, changes in the levels of bacteria in the mouth and gut will be observed, as well as any development of antibiotic resistance. The study aims to provide valuable information on the best practices for using antibiotics in dental surgeries involving bone augmentation, ultimately helping to improve patient outcomes and reduce the risk of infection.

]]>